QR678, a pioneering company dedicated to revolutionising hair and skin science through groundbreaking research and innovative solutions, has announced the appointment of Sridhar Ranganathan to its Board of Advisors.

Ranganathan, former Managing Director at Allergan, brings a wealth of expertise in biotechnology, healthcare, and aesthetics, which is expected to significantly bolster QR678's strategic direction and market penetration.

During his tenure as Managing Director at Allergan India and South Asia, Ranganathan played a pivotal role in scaling up Botox over several years, significantly expanding its market presence and transforming it into a leading product in the aesthetics industry. His leadership and strategic vision were instrumental in elevating Botox’s prominence, contributing to Allergan’s strong foothold in the market.

Ranganathan is a distinguished figure in the medtech industry, currently being part of the IIT Madras incubated enterprises including HELYXON. His role encompasses driving strategic initiatives and leveraging his extensive experience in sales, marketing, and transformational leadership. Additionally, he is a member of the Steering Committee of HRD at the Department of Biotechnology, Ministry of Science and Technology, that provides strategic directions in biotechnology education and development. Sridhar is also a IICA certified Indpendent Director.